Amp Capital Investors LTD Adma Biologics, Inc. Transaction History

Amp Capital Investors LTD

  • $0
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 13, 2019
SELL
$2.17 - $6.12 $35,588 - $100,368
-16,400 Closed
0 $0
Q3 2018

Nov 13, 2018
SELL
$4.39 - $6.85 $33,803 - $52,745
-7,700 Reduced 31.95%
16,400 $102,000
Q2 2018

Aug 13, 2018
BUY
$4.39 - $5.44 $105,798 - $131,104
24,100 New
24,100 $109,000

Others Institutions Holding ADMA

# of Institutions
319
Shares Held
185M
Call Options Held
917K
Put Options Held
91.6K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $4.29B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Amp Capital Investors LTD Portfolio

Follow Amp Capital Investors LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email